Page 9 - Read Online

Cancer Drug Resistance
CONTENTS

Topic: Pharmacogenetics of cancer

1 “Pharmacogenetics of Cancer” - Cancer Drug Resistance special issue
Enrico Mini, Stefania Nobili
Cancer Drug Resist 2020;3:225-231 http://dx.doi.org/10.20517/cdr.2020.10

2 Germline variants in cancer therapy
Meike Kaehler, Ingolf Cascorbi
Cancer Drug Resist 2019;2:18-30 http://dx.doi.org/10.20517/cdr.2019.05

3 Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
Gladys Olivera, Luis Sendra, María José Herrero, Pablo Berlanga, Pablo Gargallo, Yania Yáñez,
Andrea Urtasun, Jaime Font de Mora, Victoria Castel, Adela Cañete, Salvador F. Aliño
Cancer Drug Resist 2019;2:53-68 http://dx.doi.org/10.20517/cdr.2018.25

4 Pharmacogenetic and pharmacogenomic discovery strategies
Concetta Crisafulli, Petronilla Daniela Romeo, Marco Calabrò, Ludovica Martina Epasto,
Saverio Alberti
Cancer Drug Resist 2019;2:225-241 http://dx.doi.org/10.20517/cdr.2018.008

5 Opportunities and challenges of implementing Pharmacogenomics in cancer drug development
Paolo Tarantino, Dario Trapani, Stefania Morganti, Emanuela Ferraro, Giulia Viale, Paolo D’Amico,
Bruno Achutti Duso, Giuseppe Curigliano
Cancer Drug Resist 2019;2:43-52 http://dx.doi.org/10.20517/cdr.2018.22

6 The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with
fluoropyrimidines
Elena De Mattia, Rossana Roncato, Chiara Dalle Fratte, Fabrizio Ecca, Giuseppe Toffoli, Erika Cecchin
Cancer Drug Resist 2019;2:116-130 http://dx.doi.org/10.20517/cdr.2019.04

7 Pharmacogenetics of thiopurines
Raffaella Franca, Giulia Zudeh, Sofia Pagarin, Marco Rabusin, Marianna Lucafò, Gabriele Stocco,
Giuliana Decorti
Cancer Drug Resist 2019;2:256-270 http://dx.doi.org/10.20517/cdr.2019.004

8 Pharmacogenetics of asparaginase in acute lymphoblastic leukemia
Rachid Abaji, Maja Krajinovic
Cancer Drug Resist 2019;2:242-255 http://dx.doi.org/10.20517/cdr.2018.24

9 Pharmacogenetics of anticancer monoclonal antibodies
Dmitrii Shek, Scott A. Read, Golo Ahlenstiel, Irina Piatkov
Cancer Drug Resist 2019;2:69-81 http://dx.doi.org/10.20517/cdr.2018.20